Connect with us

Technology

Gastroesophageal Reflux Disease (GERD) Device Market to Reach USD 1.9 Billion by 2036 as Advanced Reflux Diagnostics and Minimally Invasive Procedures Improve Treatment Outcomes

Published

on

NEWARK, Del., July 1, 2026 /PRNewswire/ — The global Gastroesophageal Reflux Disease (GERD) Device Market, according to Future Market Insights, is entering a stable growth phase, driven by increasing adoption of reflux diagnostic tools, growing demand for minimally invasive anti-reflux procedures, and expanding hospital endoscopy infrastructure. The market is projected to grow from USD 1.3 billion in 2026 to USD 1.9 billion by 2036, registering a CAGR of 3.9% during the forecast period.

The market is evolving as healthcare providers increasingly prioritize objective reflux confirmation before selecting advanced treatment pathways. Device-assisted reflux management is gaining traction as physicians seek reliable diagnostic evidence through pH monitoring, manometry, and upper GI visualization.

Demand growth is being supported by rising GERD prevalence, increasing endoscopy volumes, and growing adoption of fundoplication and sphincter augmentation procedures in patients with persistent symptoms unresponsive to medication.

As clinical complexity increases, manufacturers with strong diagnostic platforms, physician training programs, reliable service networks, and minimally invasive treatment technologies are expected to secure long-term competitive advantage.

Get detailed market forecasts, competitive benchmarking, and pricing trends: https://www.futuremarketinsights.com/reports/sample/rep-gb-1741

Market Overview

The GERD device market has become one of the most strategically important segments within gastrointestinal diagnostics and treatment. Market value is increasingly driven by advanced diagnostic systems that improve reflux confirmation accuracy and treatment devices that reduce long-term symptom burden.

The market is expected to rise from USD 1.3 billion in 2026 to USD 1.9 billion by 2036, supported by rising diagnostic demand and increasing adoption of device-assisted reflux interventions.

Unlike pharmaceutical therapies, GERD devices require specialized equipment, procedural expertise, and trained gastroenterology teams. Consequently, market leadership increasingly depends on suppliers capable of combining device innovation with workflow optimization and clinical support.

Key Growth Drivers

A major growth catalyst is the increasing need for objective reflux confirmation before advanced treatment decisions. Physicians are increasingly relying on pH monitoring, manometry, and endoscopy to distinguish GERD from other overlapping gastrointestinal and throat conditions.

Minimally invasive anti-reflux procedures are another major driver. Procedures such as fundoplication and magnetic sphincter augmentation offer long-term symptom control for refractory patients while reducing recovery time.

Growing hospital investments in upper GI imaging and diagnostic infrastructure are also accelerating device adoption by improving access to integrated diagnosis and treatment.

Rising GERD prevalence globally is further supporting market growth, especially as persistent reflux is increasingly associated with complications such as esophagitis and Barrett’s esophagus.

Technology & Innovation Trends

Innovation in the GERD device market is centered around patient-friendly diagnostics, minimally invasive procedures, and procedural efficiency.Wireless pH monitoring systems are improving diagnostic accuracy while enhancing patient comfort compared to traditional catheter-based systems.Advanced endoscopic visualization platforms are improving esophageal assessment and procedural planning, allowing clinicians to better identify anatomical reflux causes.Minimally invasive treatment technologies, including magnetic sphincter augmentation and radiofrequency ablation, are gaining adoption by offering lower procedural burden and faster recovery.Digital workflow integration and procedure guidance tools are becoming increasingly important for improving treatment precision and clinical outcomes.

Analyst Perspective

“GERD device demand is becoming an extension of structured reflux care rather than a substitute for medicine. Device adoption increases after persistent symptoms and stronger diagnostic proof from endoscopy or pH monitoring. Suppliers offering reliable diagnostics, procedural training, and service support will gain stronger hospital preference,” says FMI Analyst Anurag Sharma.

Market Challenges & Restraints

Despite stable growth potential, the market faces several structural challenges.

One major barrier is the high cost of advanced GERD procedures and implantable systems. Hospitals require specialized surgeons and sufficient procedure volume to justify investment.

Pricing pressure remains another major restraint, particularly as healthcare providers face reimbursement limitations and stricter capital expenditure controls.

Training complexity also constrains adoption, especially for advanced reflux procedures requiring specialized surgical expertise.

Regulatory approval requirements for novel treatment systems further increase commercialization timelines and market entry barriers.

Segment Analysis

The GERD device market is segmented by product type, procedure, end user, technology, distribution channel, and region.

By Product Type

Esophagoscopes and gastroscopes are projected to account for 42.0% market share in 2026, supported by strong demand for upper GI visualization in reflux diagnosis.

Other major product segments include:

Manometry SystemspH Monitoring SystemsFundoplication DevicesSphincter Augmentation DevicesRadiofrequency Ablation Devices

By Procedure

Fundoplication procedures are projected to account for 35.0% market share in 2026, supported by refractory GERD cases requiring anatomical correction.

Other key procedures include:

Diagnostic ProceduresRadiofrequency Thermal AblationMagnetic Sphincter Augmentation

By End User

Hospitals are expected to dominate demand with 60.0% market share in 2026, driven by integrated diagnostic and treatment capabilities.

Other end users include:

Diagnostic CentersAmbulatory Surgical Centers

By Technology

Minimally invasive technology is projected to account for 45.0% market share in 2026, driven by faster recovery and lower procedural burden.

Other technologies include:

Endoscopic TechnologyImplantable TechnologyEnergy-Based Technology

By Distribution Channel

Direct sales are expected to dominate with 58.0% market share in 2026, supported by account-based hospital procurement.

Other channels include:

DistributorsOnline Channels

Customize insights for your business strategy: https://www.futuremarketinsights.com/customization-available/rep-gb-1741

Regional Analysis

Regional growth increasingly depends on healthcare infrastructure, reflux diagnostic access, procedural capacity, and reimbursement dynamics.

United States remains the fastest-growing major market and is expected to grow at 5.2% CAGR through 2036, supported by broad reflux testing access and advanced procedural availability.India is the second-fastest growing market with 4.5% CAGR, driven by expanding hospital endoscopy infrastructure and rising private healthcare investments.China is forecast to grow at 3.6% CAGR, benefiting from structured medical device regulations and growing hospital diagnostic capacity.Brazil is projected to expand at 3.2% CAGR, supported by private hospital investments and stronger device traceability regulations.France, Germany, and United Kingdom maintain stable growth driven primarily by replacement demand and selective procedural upgrades.

Competitive Landscape

Competition is intensifying among global endoscopy manufacturers and specialized GERD device providers.

Competitive advantage increasingly depends on:

Diagnostic accuracyImaging qualityProcedural efficiencyTraining supportService reliability

As hospital procurement becomes more outcome-driven, suppliers must deliver value beyond standalone hardware.

Leading Companies Analysis

Key market participants include Olympus Corporation, Fujifilm Holdings Corporation, and PENTAX Medical, all of which maintain strong endoscopy portfolios and global service reach.

Other important participants include:

KARL STORZJohnson & Johnson MedTechMerit Medical SystemsLABORIEDiversatek

Investment & Strategic Developments

Investment activity is accelerating in wireless reflux diagnostics, minimally invasive treatment systems, and procedural workflow optimization.

Strategic focus is increasingly shifting toward improving diagnostic confidence and procedural efficiency.

Long-term investment is also focused on reducing procedural complexity and expanding access to advanced reflux care across ambulatory and regional centers.

Investors are paying close attention to diagnostic innovation, clinical evidence, and service coverage, as these factors strongly influence long-term commercial success.

Conclusion

The Gastroesophageal Reflux Disease (GERD) Device Market is transitioning from a niche reflux treatment segment into a high-value diagnostic and procedural care market.

With the market projected to grow from USD 1.3 billion in 2026 to USD 1.9 billion by 2036, long-term growth remains steady.

Demand is increasingly tied to diagnostic precision, minimally invasive treatment pathways, and operational reliability rather than conventional equipment alone. Companies capable of combining device innovation with strong clinical support and service infrastructure will be best positioned to lead the next phase of market growth.

Future Outlook

The MRI market is expected to become increasingly technology-driven over the next decade.

Future growth will be shaped by:

Expansion of AI reconstructionGrowth of low-helium MRI systemsIncreased portable MRI adoptionFaster scan workflowsStronger hospital replacement demand

The industry is likely to continue shifting toward high-efficiency imaging platforms with improved throughput and lower operational complexity.

Conclusion

The Magnetic Resonance Imaging (MRI) Market is transitioning from a conventional equipment replacement market into a high-value technology-driven diagnostic segment.

With the market projected to grow from USD 7.0 billion in 2026 to USD 10.2 billion by 2036, long-term growth remains steady.

Demand is increasingly tied to scan efficiency, AI-enabled workflows, and operational reliability rather than conventional hardware alone. Companies capable of combining imaging innovation with strong service and workflow support will be best positioned to lead the next phase of market growth.

Explore the Latest Healthcare Industry Analysis Now:  
https://www.futuremarketinsights.com/industry-analysis/healthcare   

FMI Custom Research: Strategic Intelligence for Confident Decision-Making 

In today’s rapidly evolving business environment, leadership teams need more than market data—they need clear, actionable intelligence tailored to their strategic objectives. FMI’s Custom Research solutions are designed around the specific business questions organizations need answered, enabling executives to evaluate growth opportunities, validate investments, assess competitive dynamics, and reduce uncertainty before making critical decisions. By combining deep industry expertise, primary research, and proprietary market intelligence, FMI delivers insights that help organizations move from assumptions to evidence-based strategies with greater speed and confidence. 

Key Executive Benefits 

Decision-Ready Insights: Research tailored to your specific business challenges, growth plans, and investment priorities. Reduced Strategic Risk: Validate market opportunities, customer demand, and competitive positioning before committing resources. Market Entry Confidence: Assess opportunity size, regulatory barriers, channel dynamics, and competitive landscapes with precision. Competitive Advantage: Gain proprietary intelligence unavailable through syndicated reports or internal datasets. Faster Growth Decisions: Accelerate expansion, product development, portfolio optimization, and investment planning. Primary Market Validation: Access real-world customer, buyer, and stakeholder insights that support high-confidence decision-making. Global Industry Expertise: Powered by 100+ analysts, 20,000+ published reports, and 1.6 million+ hours of research experience. Proven Track Record: Over 7,000 market-entry engagements completed across six regions and 14 industry sectors with strong client retention. 

Business Impact 

FMI helps organizations transform market complexity into strategic clarity, enabling leadership teams to identify growth opportunities faster, optimize resource allocation, strengthen competitive positioning, and make high-stakes business decisions with confidence. 

To explore how FMI Custom Research can support your strategic priorities, please connect with our team at – sales@futuremarketinsights.com  

Related Reports: 

Electrophysiology Market – https://www.futuremarketinsights.com/reports/electrophysiology-marketBattery Powered Surgical Drill Market – https://www.futuremarketinsights.com/reports/battery-powered-surgical-drill-marketEdema Management Devices Market – https://www.futuremarketinsights.com/reports/edema-management-devices-marketIsokinetic Diagnostic and Training System Market – https://www.futuremarketinsights.com/reports/isokinetic-diagnostic-and-training-system-marketViscosupplementation Market – https://www.futuremarketinsights.com/reports/viscosupplementation-market

About Future Market Insights (FMI)  

Future Market Insights (FMI) delivers actionable, decision-focused market intelligence that goes beyond traditional research reports. The company provides:  

In-depth pricing and cost benchmarking analysis  Demand forecasting based on real industry inputs  Procurement and buyer behavior insights  Supply chain and trade flow intelligence  Technology and application trend analysis across industries  

FMI follows a robust bottom-up research methodology, combining insights from industry experts, procurement leaders, manufacturers, and technical professionals to ensure accurate and practical market intelligence.  

For Press & Corporate Inquiries   

Rahul Singh    
AVP – Marketing and Growth Strategy    
Future Market Insights, Inc.    
+91 8600020075    
For Sales - sales@futuremarketinsights.com    
For Media - Rahul.singh@futuremarketinsights.com    
For web - https://www.futuremarketinsights.com/    
For Web - https://www.factmr.com/

Logo – https://mma.prnewswire.com/media/1197648/6020102/FMI_Logo.jpg

View original content to download multimedia:https://www.prnewswire.com/news-releases/gastroesophageal-reflux-disease-gerd-device-market-to-reach-usd-1-9-billion-by-2036-as-advanced-reflux-diagnostics-and-minimally-invasive-procedures-improve-treatment-outcomes-302816004.html

SOURCE Future Market Insights

Continue Reading

Technology

Korean Buyers Invited to Connect with Chinese Suppliers at C-TOUCH & DISPLAY and FILM & TAPE EXPO 2026

Published

on

By

SHENZHEN, China, Oct. 20, 2026 /PRNewswire/ — Featuring Korea Day business matchmaking, next-generation display technologies and advanced functional materials, the October exhibitions offer Korean industry professionals new opportunities to explore suppliers and strengthen cross-border partnerships.

As demand grows for advanced displays, semiconductor technologies and high-performance materials, C-TOUCH & DISPLAY SHENZHEN 2026 and FILM & TAPE EXPO 2026 will welcome Korean buyers and industry professionals to Shenzhen, China, from October 27–29. The exhibitions will provide opportunities to discover new technologies, meet Chinese manufacturers and explore business partnerships across the electronics, display, automotive and advanced materials supply chains.

C-TOUCH: Exploring Next-Generation Display and Semiconductor Technologies

C-TOUCH & DISPLAY SHENZHEN 2026 will showcase technologies spanning OLED, Micro LED, flexible displays, touch panels, e-paper, commercial displays, automotive displays and AI+AR smart glasses. As display technologies converge with AI computing, optical communications and semiconductor packaging, the exhibition will connect Korean visitors with suppliers developing materials, components, manufacturing equipment and integrated solutions.

A key highlight is the TGV Glass Substrate Advanced Packaging Zone, where visitors can explore eight major process stages, including laser induction, etching, chemical vapor deposition (CVD), physical vapor deposition (PVD), electroplating, chemical mechanical planarization (CMP), coating and photolithography.

FILM & TAPE EXPO: Functional Materials for Electronics and Advanced Manufacturing

FILM & TAPE EXPO 2026 will bring together suppliers of functional films, optical films, protective and release films, polyimide (PI) films, adhesive tapes, optical clear adhesives (OCA), thermal-management materials and precision converting equipment.

The exhibition will also cover coating, laminating, slitting, rewinding, inspection and die-cutting technologies. These solutions support applications across consumer electronics, semiconductors, automotive electronics, batteries and energy storage, PCB/FPC and industrial manufacturing.

Korea Day: Connecting Korean Buyers with Chinese Suppliers

A major opportunity for Korean visitors will be Korea Day, a dedicated buyer–supplier matchmaking initiative designed to facilitate business connections between Korean industry professionals and Chinese suppliers.

The program will provide a focused setting for buyers to communicate their sourcing needs, explore relevant products and technologies, and discuss potential cooperation directly with suppliers. For companies seeking new sourcing options, manufacturing partners or materials for product development, Korea Day can help make exhibition visits more targeted and productive.

Easier Travel: China’s 30-Day Visa-Free Policy for South Korean Citizens

Travel planning has also become more convenient for eligible Korean visitors. Under China’s current unilateral visa-free policy, South Korean citizens holding ordinary passports may enter China without a visa for stays of up to 30 days for business, tourism, family or friends visits, exchange visits and transit.

The policy has been extended through December 31, 2026. Visitors should consult the Chinese Embassy in the Republic of Korea for the latest official guidance.

Register to Visit Shenzhen This October

C-TOUCH & DISPLAY SHENZHEN 2026 and FILM & TAPE EXPO 2026 will take place October 27–29 at Shenzhen World Exhibition & Convention Center in Bao’an, Shenzhen, China.

C-TOUCH & DISPLAY SHENZHEN 2026: Pre-register here

FILM & TAPE EXPO 2026: Pre-register here

About RX Kuozhan

RX Kuozhan is a joint venture between Reed Exhibitions and Kuozhan Exhibition Services (Shanghai) Co., Ltd., established in 2015. The company organizes a portfolio of industry-leading exhibitions serving the display, touch technology, functional films, adhesive materials, commercial display and advanced materials sectors. Through its exhibitions and industry engagement initiatives, RX Kuozhan connects manufacturers, technology providers, buyers and industry professionals, facilitating business partnerships, technology exchange and cross-industry collaboration in China and international markets.

For more information, please visit C-TOUCH & DISPLAY SHENZHEN and FILM & TAPE EXPO.

View original content:https://www.prnewswire.com/apac/news-releases/korean-buyers-invited-to-connect-with-chinese-suppliers-at-c-touch–display-and-film–tape-expo-2026-302912105.html

SOURCE RX Kuozhan

Continue Reading

Technology

What’s Next for Webull Corporation Shareholders After 19.09% Stock Drop? Glancy Prongay Wolke & Rotter LLP Explains Securities Fraud Class Action Lead Plaintiff Deadline

Published

on

By

Complaint alleges Webull Corporation misled investors between April 26, 2025 and October 6, 2026; investors may seek lead plaintiff role by December 7, 2026

LOS ANGELES, Oct. 19, 2026 /PRNewswire/ — Glancy Prongay Wolke & Rotter LLP (“Glancy”) announced today that the class action lawsuit covers investors who bought Webull Corporation (“Webull” or the “Company”) (NASDAQ: BULL) securities between April 26, 2025 and October 6, 2026. The Webull Corporation case, Ward v. Webull Corporation et al., was filed on October 8, 2026 in the U.S. District Court Middle District of Florida (Tampa) (Case No. 8:26-cv-03052).

Investors who suffered losses on Webull Corporation investments can submit their Webull Corporation loss information here before the December 7, 2026 lead plaintiff deadline.

Key dates in the Webull Corporation case

Class period: April 26, 2025 to October 6, 2026Complaint filed: October 8, 2026Lead plaintiff deadline: December 7, 2026

What happened?

On October 7, 2026, the bipartisan House Select Committee on China issued a report which found “a profound gap” between Webull’s public marketing as “an American company” and actual control of the alleged St. Petersburg, Florida-based firm. The committee reportedly found “Webull’s ownership architecture, technical workforce, technology infrastructure, cross-border data routing, corporate financing, and compliance frameworks are tied in structural ways to the People’s Republic of China.” The Select Committee also reportedly found that Webull initially told the Select Committee that it had no offices or employees in China, while Webull’s mainland China subsidiary in fact employed approximately 863 employees, or 62% of Webull’s global workforce.

Webull Corporation stock fell $1.39 or 19.09%, to close at $5.89 on October 7, 2026, thereby injuring investors.

What is the Webull Corporation lawsuit about?

The Webull Corporation securities lawsuit alleges that, between April 26, 2025 and October 6, 2026, defendants made materially false and/or misleading statements and failed to disclose material adverse facts about Webull Corporation’s business, operations, and prospects. Specifically, the complaint alleges defendants failed to disclose that: (1) Webull’s mainland China operations were not limited to research and development and technical support functions, but rather Webull’s software development, data pipelines, and core engineering depended on PRC-based personnel and on infrastructure subject to Chinese law; (2) Webull’s ownership structure, technical workforce, technology infrastructure, cross-border data routing, financing, and compliance structure were structurally tied to China; (3) as a result, Webull’s representations that its principal business operations were based in the U.S. and that its U.S. customer data was insulated from non-U.S. access materially overstated Webull’s independence from the PRC; and (4) as a result, defendants’ positive statements about Webull Corporation’s business, operations, and prospects were materially misleading and/or lacked a reasonable basis.

“The complaint filed against Webull Corporation alleges that, among other things, the Company failed to disclose that Webull’s mainland China operations were not limited to research and development and technical support functions, but rather Webull’s software development, data pipelines, and core engineering depended on PRC-based personnel and on infrastructure subject to Chinese law. For investors who bought during the class period, the December 7, 2026 deadline is the first major step in this case,” said Charles H. Linehan, Partner at Glancy Prongay Wolke & Rotter LLP.

What’s the next step?

Glancy Prongay Wolke & Rotter LLP is a leading national shareholder rights law firm, ready to assist Webull Corporation investors in potentially pursuing claims to recover their losses.

If you wish to serve as lead plaintiff in the Webull Corporation class action, you must move the Court no later than December 7, 2026. To learn more about your rights, visit the Webull Corporation case page, email shareholders@glancylaw.com, or call 310-201-9150 (toll-free: 888-773-9224).

You may retain counsel of your choice. If you bought Webull Corporation securities during the class period, you may take no action and remain an absent class member. No class has been certified yet in the Webull Corporation case.

Frequently Asked Questions

Who is eligible? Investors who purchased or otherwise acquired Webull Corporation securities between April 26, 2025 and October 6, 2026 and suffered losses may be members of the proposed class in the Webull Corporation shareholder lawsuit. Any class member may ask the court to appoint them lead plaintiff by December 7, 2026.

What is a lead plaintiff? In the Webull Corporation class action, the lead plaintiff is the investor, or group of investors, that the court appoints to represent all class members and oversee the case. Under the Private Securities Litigation Reform Act, courts generally presume the movant with the largest financial interest is the most adequate lead plaintiff.

Do I have to be lead plaintiff to recover? No. A Webull Corporation investor’s ability to share in any future recovery does not depend on serving as lead plaintiff. Webull Corporation investors may take no action and remain absent class members.

What is the deadline? Motions to serve as lead plaintiff in the Webull Corporation class action must be filed by December 7, 2026.

Does it cost anything to contact Glancy or participate in this action? Glancy represents Webull Corporation investors on a contingency fee basis, which means investors pay no attorneys’ fees unless there is a recovery. Any fees are subject to court approval and are paid from the recovery.

Can I choose my own lawyer? Yes. Webull Corporation investors may retain counsel of their choice.

Why work with Glancy on the Webull Corporation lawsuit? Glancy Prongay Wolke & Rotter LLP is a premier law firm with decades of experience representing investors and consumers in securities litigation and other complex class action litigation. Contact Glancy about the Webull Corporation lawsuit. Prior results do not guarantee a similar outcome.

About Glancy Prongay Wolke & Rotter LLP

Glancy was named one of Law360’s Securities Groups of the Year and ranked second in total investor recoveries by ISS Securities Class Action Services in 2025.

Glancy’s successes have been widely covered by leading news and industry publications, including The Wall Street Journal, The Financial Times, Bloomberg Businessweek, Reuters, the Associated Press, Barron’s, Investor’s Business Daily, Forbes, and Money.

Prior results do not guarantee a similar outcome.

Related links

Webull Corporation case page, Glancy Prongay Wolke & Rotter LLPComplaint: Ward v. Webull Corporation et al., U.S. District Court Middle District of Florida (Tampa)Webull Corporation SEC filings index, EDGARGlancy Prongay Wolke & Rotter LLP

CONTACT:
Charles H. Linehan
Glancy Prongay Wolke & Rotter LLP
1925 Century Park East, Suite 2100
Los Angeles, CA 90067
Email: shareholders@glancylaw.com
Telephone: 310-201-9150 | Toll-free: 888-773-9224
www.glancylaw.com

Follow Glancy on LinkedIn, X, or Facebook.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.

View original content to download multimedia:https://www.prnewswire.com/news-releases/whats-next-for-webull-corporation-shareholders-after-19-09-stock-drop-glancy-prongay-wolke–rotter-llp-explains-securities-fraud-class-action-lead-plaintiff-deadline-302913255.html

SOURCE Glancy Prongay Wolke & Rotter LLP

Continue Reading

Technology

NetDragon Partners with Jiuzhou Culture to Establish Joint Venture

Published

on

By

Takes Controlling Stake in AI Harness Business to Advance a Third Growth Engine

HONG KONG, Oct. 19, 2026 /PRNewswire/ — NetDragon Websoft Holdings Limited (“NetDragon” or the “Company”; Hong Kong Stock Code: 0777), a global leader in building internet communities, is pleased to announce that it has entered into a legally binding memorandum of understanding (“MOU”) with Jiuzhou Culture (“Jiuzhou”), a leading AIGC short drama production and distribution company in China, to establish a joint venture (“JV”) in which NetDragon will hold a 51% controlling interest. The partnership will focus on artificial intelligence technologies, AIGC-powered content creation and digital technology services, further expanding NetDragon’s AI application scenarios and commercialisation opportunities while accelerating the development of a new growth engine.

Deepening the Integration of AIGC and Content to Build a Diversified Digital Business Platform

Rapid advances in AIGC are continuing to reshape content creation, digital entertainment and software services. With the ongoing maturation of generative AI, large-scale AI models and AI agents, AI is evolving from a supporting tool into a productivity platform that can enhance the entire value chain, from content creation and production to operations and commercialisation. Through the JV Company, NetDragon and Jiuzhou will combine their complementary strengths in technology, IP, content and industry resources to accelerate the deployment of AIGC across real-world commercial applications.

Under the MOU, Jiuzhou will inject into the JV Company all intellectual property, technologies and assets relating to the AI Harness system business, laying a solid foundation for product development and commercialisation. NetDragon will contribute Hong Kong dollars cash equivalent to RMB 50 million to the JV Company, acquire a 51% shareholding interest and consolidate the JV Company’s financial results. The JV Company will focus on expanding foundational artificial intelligence software, large-scale AI models and the AI Harness system business. It is expected to serve as the first commercial validation platform in China for NetDragon’s “AI ecosystem co-creation” strategy, marking the launch of the Company’s third growth engine and laying the groundwork for the business model to be replicated and scaled across various sectors.

To accelerate the scalable commercialisation of the AI Harness business, the transaction also incorporates a multi-tiered, progressive performance-based incentive warrant scheme. NetDragon will issue 25 million unlisted warrants to Jiuzhou at an issue price of HK$0.10 per warrant share, to be granted in three tranches with initial exercise prices of HK$10, HK$12 and HK$15, respectively. The warrants will only become exercisable upon achievement of specified key performance indicators by the JV Company. Assuming full exercise of all warrants at the initial exercise prices, NetDragon will receive aggregate gross proceeds of approximately HK$314 million, which will supplement the Company’s development capital while achieving deep alignment of interests and shared equity upside with its strategic partner. 

Strengthening AI Ecosystem Synergies to Drive a Third Growth Engine

As generative AI becomes increasingly integrated into content production, digital services and global operations, NetDragon and Jiuzhou will take this collaboration as a new starting point to fully leverage their complementary strengths and accelerate the commercialisation of AI capabilities, translating technological innovation into tangible business value. In recent years, NetDragon has continued to advance its AI strategy across AI+gaming, AI+education and enterprise intelligence, while actively exploring emerging AI businesses with the potential to establish independent commercial models. Jiuzhou, meanwhile, has built deep expertise in micro-dramas and digital content, with an integrated value chain spanning copyright operations, content creation, co-production, paid distribution and official distribution. It has also continued to expand the use of AIGC across content production, creation and operations. The two parties will further explore the deep integration of AI technology with the content industry, accelerating the implementation of AI capabilities in scenarios such as content generation, AI model applications, translation and localisation, platform operations, and enterprise technology services, to build scalable and sustainable business models.

Following the launch of the MOYU AI platform in August 2026, NetDragon’s investment and controlling stake in the AI Harness business marks another important step in increasing resource allocation to its AI business and broadening its long-term growth pathways. The performance-linked equity incentive collaboration with Jiuzhou is expected to establish a new model of strategic collaboration for NetDragon, enabling the Company and its partners to grow the business together and share in the value created. Looking ahead, NetDragon will remain focused on its core AI business, deepen technological innovation and resource integration, and leverage its established strengths in gaming and education alongside the emerging growth engine of AI ecosystem co-creation. Under this three-pronged strategy, the Company aims to continuously strengthen its core competitiveness, enhance long-term investment value, and deliver sustainable returns to shareholders.

About NetDragon Websoft Holdings Limited

NetDragon Websoft Holdings Limited (HKSE: 777) is a global leader in building internet communities, with a long track record of developing and scaling multiple internet and mobile platforms that impact hundreds of millions of users. Over the desktop and mobile internet eras, NetDragon previously established China’s first online gaming portal, 17173.com, and China’s most influential smartphone app store platform, 91 Wireless.   

Established in 1999, NetDragon is one of the most reputable and well-known digital entertainment IP developers and operators in China with a history of successful flagship game titles deeply welcomed by users both at home and abroad. For more than a decade, NetDragon has also achieved success with its EdTech business both domestically and globally. Fully embracing the new AI era, NetDragon is driving its vision of “Infinite Growth” through AI-enabled digital entertainment and online learning, whilst building a systematic AI product methodology to create value growth.

NetDragon’s overseas edtech business entity, currently a U.S.-listed subsidiary named Mynd.ai, is a global leader in interactive technology and its award-winning interactive displays and software can be found in more than 2 million learning and training spaces across 126 countries. 

About Jiuzhou Culture

Founded in 2021, Jiuzhou is a leading player in the online micro-drama industry, with an integrated business model spanning copyright operations, content creation, co-production, paid distribution and official distribution. The company has established a comprehensive, end-to-end content ecosystem designed to enhance operational efficiency and unlock synergies across the value chain. Embracing technological innovation, Jiuzhou actively integrates cutting-edge technologies such as AIGC to enhance content quality and creative capabilities. Its self-developed Moss tool has accelerated AI adoption across the entire value chain, leveraging technology to advance the development of the global short drama ecosystem.

In terms of content creation, Jiuzhou has accumulated the rights to more than 4,000 short dramas and has successfully distributed over 1,000 productions. Its portfolio spans more than 20 popular genres, including contemporary drama, romance, campus life, fantasy, suspense and historical fiction, catering to the diverse entertainment preferences of audiences in China and worldwide. By combining paid content, free-to-view short dramas and international expansion, Jiuzhou has developed a distinctive business ecosystem that strengthens its competitive position and drives continued innovation in the micro-drama industry.

Internationally, the company leverages its strengths in content production, audience reach and distribution networks to bring Chinese micro-dramas to global audiences while tailoring its offerings to local tastes and cultural preferences. Its flagship international platform, ShortMax, focuses primarily on North American and European markets, offering a wide selection of localized Chinese dramas and original productions. ShortMax is now available in more than 200 countries and regions worldwide, having achieved peak monthly active users (MAU) of over 30 million, more than 90 million cumulative registered users and 200 million downloads.

View original content to download multimedia:https://www.prnewswire.com/news-releases/netdragon-partners-with-jiuzhou-culture-to-establish-joint-venture-302913397.html

SOURCE NetDragon Websoft Holdings Limited

Continue Reading

Trending